Financials
- Market Capitalization 1.11 B
- Employee 70
- Founded 1995
- CEO N/A
- Website www.savarapharma.com
- Headquarter Delaware, United States
- FIGI BBG000MS0823
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-10.62
Fiyat/satışlar oranı
-10.99 K
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2376 | KURA Kura Oncology, Inc. - Common Stock | 12.85 USD | +1.58% | -6.14% | +42.46% | +60.83% | 1.14 B USD | ||
| 2379 | JANX Janux Therapeutics, Inc. - Common Stock | 18.87 USD | +3.57% | +0.32% | +23.82% | -17.45% | 1.15 B USD | ||
| 2415 | SLDB Solid Biosciences Inc. - Common Stock | 9.88 USD | +3.13% | +0.92% | +24.59% | +73.33% | 1.06 B USD | ||
| 2423 | AVTX Avalo Therapeutics, Inc. - Common Stock | 19.27 USD | -0.36% | -1.83% | +5.53% | +108.10% | 1.03 B USD |